Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls
Top Cited Papers
- 1 May 2002
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 359 (9318) , 1686-1689
- https://doi.org/10.1016/s0140-6736(02)08594-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID studyThe Lancet, 2000
- Implications of trial results: the potentially misleading notions of number needed to treat and average duration of life gainedThe Lancet, 2000
- Comparison of losartan and captopril in ELITE IIThe Lancet, 2000
- Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE IIThe Lancet, 2000
- Calculating the number needed to treat for trials where the outcome is time to an eventBMJ, 1999
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuriaThe Lancet, 1999
- Assessing treatment-time interaction in clinical trials with time to event data: a meta-analysis of hypertension trialsStatistics in Medicine, 1998
- Review of survival analyses published in cancer journalsBritish Journal of Cancer, 1995
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958